NASDAQ:CYTK

Cytokinetics Stock Forecast

etoro logo Buy CYTK
*Your capital is at risk
$78.78
+0.670 (+0.86%)
At Close: Jun 18, 2026
AI Analysis AI Analysis of CYTK AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CYTK to Watchlist?
Some Reasons Why To Add CYTK:
  • +142.9% price growth over the last year
  • High gross margin of 90.3%
  • Strong return on equity of 139.7%
PDF

Cytokinetics stock price up 0.86% on Thursday
(Updated on Jun 18, 2026)

Buy candidate since Jun 16, 2026 Gain 4.75%

The Cytokinetics stock price gained 0.86% on the last trading day (Thursday, 18th Jun 2026), rising from $78.11 to $78.78. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 3.90% from a day low at $77.14 to a day high of $80.15. The price has risen in 7 of the last 10 days and is up by 8.98% over the past 2 weeks. Volume fell on the last day by -233 thousand shares and in total, 3 million shares were bought and sold for approximately $242.82 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 20.32% during the next 3 months and, with a 90% probability hold a price between $82.31 and $100.15 at the end of this 3-month period.

CYTK Signals & Forecast

The Cytokinetics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $72.85 and $73.58. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 17.46%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Cytokinetics stock

Cytokinetics finds support from accumulated volume at $77.09 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.01 between high and low, or 3.90%. For the last week, the stock has had daily average volatility of 4.41%.

Since the Cytokinetics has been rising for 6 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stop-loss: $76.09 (-3.42%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (CYTK) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Cytokinetics to open at $78.69, and during the day (based on 14 day Average True Range), to move between $77.18 and $80.38, which gives a possible trading interval of +/-$3.19 (+/-4.14%) up or down from last closing price. If Cytokinetics takes out the full calculated possible swing range there will be an estimated 4.14% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $77.09, some $1.69 (2.15%) from the current price of $78.78, our system finds the risk reward attractive.

Is Cytokinetics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Cytokinetics stock to perform well in the short-term.

Current score: 3.881 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $78.69 ( 0.114%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CYTK Performance

Trading levels for CYTK

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 81.70 3.71%
R2 80.55 2.25%
R1 79.84 1.35%
Price 78.78
S1 77.54 -1.57%
S2 76.83 -2.48%
S3 75.68 -3.94%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 78.78
S1 77.09 -2.15%
S2 76.91 -2.37%
S3 74.29 -5.70%

FAQ

What is the symbol for Cytokinetics Stock and on which exchange is it traded?
The symbol for Cytokinetics is CYTK and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cytokinetics Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Cytokinetics stock to perform well in the short-term.

How to buy Cytokinetics Stock?
Cytokinetics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cytokinetics Stock.

What's the current price of Cytokinetics Stock?
As of the end of day on the Jun 18, 2026, the price of an Cytokinetics (CYTK) share was $78.78.

What is the 52-week high and low for Cytokinetics Stock?
The 52-week high for Cytokinetics Stock is $80.18 and the 52-week low is $31.99.

What is the market capitalization of Cytokinetics Stock?
As of the Jun 18, 2026, the market capitalization of Cytokinetics is 9.803B.

When is the next earnings date for Cytokinetics?
The upcoming earnings date for Cytokinetics is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT CYTOKINETICS
Cytokinetics
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE